Emergent snaps up Adapt and its opioid overdose therapy for $735m
August 29, 2018Research and Development, Sales and Marketing Emergent, Narcan, naloxone, opioid crisis, opioids, pharma
Emergent BioSolutions has announced it has signed an agreement to acquire Adapt Pharma at a valuation of $735 million, a …
NHS guidance suggests mental health therapists should be brought into GP surgeries
August 29, 2018Research and Development England, GP, NHS, guidance, psychology, psychotherapy
New NHS guidelines will encourage doctors to incorporate mental health therapists into practice surgeries in an effort to bring more …
FDA warns against King Bio products after company expands recall
August 29, 2018Research and Development Contamination, FDA, homeopathy, king bio, recall
The US Food and Drug Administration is warning consumers and pet owners not to use products that have been manufactured …
Novartis to create 450 new jobs at Aargau site after Kymriah thumbs up
August 29, 2018Research and Development CAR T, CAR-T, Jobs, Kymriah, Novartis
Swiss multinational Novartis is set to create up to 450 new jobs following the investment of 90 million Swiss Francs …
Eisai’s weight loss drug lorcaserin found safe in major study
August 28, 2018Manufacturing and Production, Research and Development, Sales and Marketing Eisai, lorcaserin, safety, study, weight loss
Eisai’s weight loss drug lorcaserin does not increase people’s risk of major cardiovascular events according to a study of 12,000 …
Ionis/Akcea’s ultra-rare disease drug rejected by FDA
August 28, 2018Manufacturing and Production, Sales and Marketing Akcea, FDA, Ionis, familial chylomicronemia syndrome, pharma, rare disease
The FDA has opted to refuse approval to Akcea and Ionis’ Waylivra (volanesorsen) for the treatment of the ultra-rare hereditary …
Researchers develop anti-nicotine addiction drugs
August 28, 2018Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university
Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …
Novartis’ Kymriah & Gilead’s Yescarta become first EU-approved CAR T therapies
August 28, 2018Manufacturing and Production, Sales and Marketing CAR T, CAR-T, Cancer, EU, Gilead, Kymriah, Novartis, UK, Yescarta, blood cancer, pharma
Almost one full year since the treatment was given a “historic” approval in the US, Novartis’ CAR T therapy Kymriah …
Russian trolls spread vaccine misinformation on Twitter
August 28, 2018Manufacturing and Production, Medical Communications, Sales and Marketing Russia, misinformation, public health, study, vaccines
Twitter bots and Russian trolls post content about vaccination at significantly higher rates than normal users, a new study has …
Dompé gives the FDA its first approved neurotrophic keratitis treatment
August 24, 2018Medical Communications, Sales and Marketing Dompe, FDA, Oxervate, eye disease, pharma
Milan-based biotech firm Dompé has revealed that the FDA has awarded approval in the US to its Oxervate (cenegermin-bkbj ophthalmic …
Top Ten most popular articles on Pharmafile.com this week
August 24, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing India, Ireland, manufacturin, san francisco, top 10
As summer comes to an end manufacturing dominated the news, with jobs lost in both Ireland and San Francisco. Meanwhile …
Homeopathic medicines specialist King Bio enacts nationwide recall
August 24, 2018Medical Communications asheville, homeopathy, king bio, nc, recall
The Asheville-based drug maker King Bio is recalling 32 children’s medicines because of potential ‘microbial contamination’. The homeopathic medicines specialist …
Generics could save US Medicare $1 billion per year
August 24, 2018Medical Communications Medicare, United States, branded, generics, marketing, savings
The United States national health insurance programme Medicare could have save $1 billion through the use of generic drugs according …
Government publishes no-deal Brexit guidance, health secretary tells pharma companies to stockpile medicines
August 24, 2018Medical Communications ABPI, EU, UK, brexit, government, stockpiling
The British Government has published a document offering guidance as to what should be expected in the case of a …
GE Healthcare set to open biotech hub in Uppsala, Sweden
August 23, 2018Manufacturing and Production, Research and Development GE Healthcare, Sweden, Testa Centre, Uppsala, biotech
The American multinational GE Healthcare is opening a 27,000-sq-ft innovation centre in Uppsala, Sweden in an effort to boost the …
AstraZeneca shocked as inhaler fails to outclass GSK rival in COPD
August 23, 2018Research and Development AstraZeneca, COPD, GSK, anoro, inhaler, pharma
Researchers at AstraZeneca have been left scratching their heads as new Phase 3b results for its inhaler, Bevespi Aerosphere, posted …
$3 million GSK verdict thrown out of court
August 23, 2018Sales and Marketing GSK, Litigation, antidepressants, suicide, verdict
A $3 million verdict against British multinational GlaxoSmithKline has been thrown out after a US appeals court said that GSK …
Novartis’ investigational combo impresses in breast cancer sub-group
August 23, 2018Research and Development Cancer, Novartis, breast cancer, fulvestrant, pharma
Novartis has revealed positive new data for its investigational alpha-specific PI3K inhibitor BYL719 (alpelisib) combined with fulvestrant in the treatment …
Nerve stimulation treatments improve quality of life in depressed people, study shows
August 23, 2018Research and Development VNS, depression, neuroscience, psychiatry, quality of life, vagus nerve stimulators
Nerve stimulation treatments can significantly improve depressed people’s quality of life, even in cases in which an individual continues to …
FDA refuses Allergan’s uterine bleeding therapy with a request for more data
August 22, 2018Research and Development, Sales and Marketing Allergan, Esmya, FDA, pharma
Allergan has shared the news that the FDA has refused to award marketing authorisation to its ulipristal acetate product Esmya …
